А Б В Г Д Е Ж З И К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Э Ю Я
0-9 A B C D I F G H IJ K L M N O P Q R S TU V WX Y Z #


Чтение книги "Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников" (страница 70)

   Дополнение к главе 2

   1. Clarke, M.F. and Becker, M.W, 2006. Stem cells: the real culprits in cancer? Scientific American, July 2006, 53–59.
   2. Study reveals how growth factors affect human stem cells. www.hhmi.org/news/melton.hmtl
   3. Murray, R.K., Granner, D.K., Mayes, P.A. and Rodwell, VW, 1990. Harper's Biochemistry. Appleton and Lange Norwalk, CT, p. 653.
   4. Woolf, Neville, 1998. Pathology, Basic and Systemic. WB. Saunders Publishing Co., Chapter 28, p. 274, Figure 28.
   5. www.intouchlive.com/cancergenetics/onco.htm
   6. Ludwig, Т., Fisher, P., Ganesan, S. and Efstratiadis, 2001. Tum-origenesis in mice carrying a truncating BRCA1 mutation. Genes and Development, Vol. 15 (10), 1188–1193.
   7. Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, Т., Hennighausen, L., Wynshaw-Boris, A. and Deng, C.X. 1999. Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nature Genetics, Vol. 22 (1), 37–43.
   8. Pauli, T.T, Cortez, D., Bowers, B., Elledge, S.J. and Geliert, M., 2001. Direct DNA binding by BRCA1. Proceedings of the National Academy of Sciences of the USA, Vol. 98 (11), 6086–6091.
   9. Jensen, R.A., Thompson, M.E., Jetton, T.L., Szabo, C.I., van der Meer, R., Helou, В., Tronick, S., King, M.C., Page, D.L. and Holt, J.T., 1996. BRCA1 is secreted and exhibits properties of a granin. Nature Genetics, 12, 303–308; www.mc.vander-bilt.edu/cancer/research/ roster/jensen.html
   10. Struewing, J.P., Abeliovich, D., Peretz, Т., Avishai, N., Kaback, M.M., Collins, F.S. and Brody, L.C., 1995. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi-Jewish individuals. Nature Genetics, 11, 198–200;
   http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html
   11. Roa, B.B., Boyd, A.A., Volcik, K. and Richards, C.S., 1996. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genetics, 14, 185–187; Oddoux, C., Struewing, J.P., Clayton, C.M., Neuhausen, S., Vrody, L.C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., Golgar, D., Ostrer, H. and Offit, K., 1996. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1 %. Nature Genetics, 14, 188–190; http://rex.nci.nih.gov/massmedia/back-grounders/ashkenazi.html
   12. www.mercola.com/2002/apr/27/sv40.htm
   13. Hursting, S.D., Slaga,T.J., Fischer, S.M., DiGiovanni, J. and Phtans, J. M., 1999. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. Journal of the National Cancer Institute, 35, 2031–2038.
   14. Cheeseman, K.H. and Slater, T.F., 1993. Free Radicals in Medicine. Churchill Livingston.
   15. Cheesernan, K.H. and Slater, T.F., 1993. Free Radicals in Medicine. Churchill Livingston.
   16. Stewart, H.J., 1989. Clinical experience in the use of antioestrogen tamoxifen in the treatment of breast cancer. Proceedings of the Royal Society of Edinburgh, 95B, 231–237.
   17. Miller, W R., 1997. Aromatase inhibitors and breast cancer. Cancer Treatment Reviews, 23, 113–131.
   18. Dao, T.L., Sinha, D.K., Nemato, T. and Patel, J., 1982. Effects of estrogens and progesterone on cellular replication of human breast tumours. Cancer Research, 42, 359–362.
   19. Conte, P.P., Fraschini, G. and Dewinko, B., 1985. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer.Journal of Steroid Biochemistry, 23, 1169–1172.
   20. Miller, WR. and Langdon, S.P., 1997. Hormonal, growth factor and cytokine control of breast cancer. In: Biology of Female Cancers, pp. 43–60. Langdon, S,P., Miller, WR. and Berchuck, A. (editors). New York: CRC Press.
   21. Miller, WR., 1991. Oestrogens and breast cancer: biological considerations, British Medical Bulletin, 47, 470–483.
   22. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst, 92, 1472–1489.
   23. Rose, Steven, with Mileusnic, Radmila, 1999. The Chemistry of Life. Fourth (revised) edition. Penguin Books.
   24. Voet, Donald and Voet, Judith, 1995. Biochemistry. Second edition. John Wiley & Sons, Inc.
   25. Jiang, Wen G., Matsumoto, Kunio and Nakamura, Toshikazu (editors), 2001, Growth Factors and their Receptors in Cancer Metastasis. Dordrecht: Kluwer Academic Publishers.
   26. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst, 92, 1472–1489.
   27. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst, 92, 1472–1489.
   28. www.ucop.edu/srphome/bcrp/progressreport/abstracts/ innov/3CB-0186.html
   29. Yu, H. and Rohan, Т., 2002. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst, 92, 1472–1489.
   30. www.preventcancer.com/pdf/InsulinGrowth266.html

   Дополнение к главе 3

   1. www.dep.iarc.fr/globocan/database.pdf
   2. WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P. and Parkin, D.M. (editors), www.dep.iarc. fr/globocan/ database.pdf
   3. American Cancer Society. Modelled data: cancer facts and figures, 2006.
   4. www.cancerresearchuk.org
   5. www.cancerresearchuk.org
   6. www.cancerresearchuk.org
   7. Pike M.C., Kolonel, L.N., Henderson, B.E., Wilkens, L.R., Hankin J.H., Feigelson, H.S., Wan, P.C., Stram, D.O. and Nomura, A.M., 2002. Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev, 11 (9), 795–800.
   8. www.hawaii.edu/crch/ProfileKolonel.htm
   9. www.yoursurgery.com/ProcedureDetails.cfm?BR=3&Proc=36
   10. American Cancer Society. Modelled data: cancer facts and figures, 2006.
   11. Worldwide Cancer Mortality Statistics, ASR(w) for Annual Mortality per 100 000 by sex and age group, http://www.depd. iarc.fr/who/menu.htm
   12. Yancik, R. and Ries, L.A., 1994. Cancer in older persons. Magnitude of the problem: how do we apply what we know? Cancer, 74 (7 Suppl), 1995–2003.
   13. Silliman, R.A. and Baeke, P., 1998. Breast cancer in the older woman. In: Balducci, L., Ersher, WB. and Lyman, G.H. Comprehensive geriatric oncology. Amsterdam: Harwood.
   14. Welch, H.G., Albertson, P.O., Nease, R.E, Bubolz, T.A. and Wasson, J.H., 1996. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med, 124, 577–584.
   15. Campbell, T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health. Ben-bella Books.
   16. Dobson, R., 2006. Breast cancer incidence rises in contaminated areas 10 years after explosion at Chernobyl reactor. BMJ, 332, 567.
   17. Jakes, R.W and others, 2002. Mammographie parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiological Biomarkers Prev, 11, 608–613.
   18. www.cancer.org;
   www.cancer.org/docroot/CRI/content/CRl_2_4_2X_What_ are_the_risk_factors_for_breast_cancer_5.asp
   19. Dobson, R., 2006. Diethylstilbestrol increase risk of breast cancer death. BMJ, 333, 64.
   20. www.cancer.org/docroot/CRI/content/CRI_2_4_2X_What_ are_the_risk_factor s_for_male_breast_cancer_28.asp
   21. www.dep.iarc.fr/globocan/database.pdf
   22. WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P. and Parkin, D.M. (editors), www.dep.iarc. fr/globocan/ database.pdf
   23. Campbell, T.C., and Junshi, C., 1994. Diet and chronic degenerative disease perspectives from China. American Journal of Clinical Nutrition, 59, Suppl., 11 535-11 615.
   24. Jakes, Rupert W, Duffy, Stephen Ж., Ng, Fook-Cheong, Gao, Fei, Ng, Eng-Hen, Seow, Adeline, Lee, Hin-Peng and Yu, Mimi C., 2002. Mammographic Parenchymal Patterns and Self-re-ported Soy Intake in Singapore Chinese Women. Cancer Epidemiology Biomarkers & Prevention, 11, 608–613.
   25. Statistical Abstracts of the US, 1994 edition.
   26. T. Colin Campbell, quoted in www.milksucks.com/osteo.html; Robbins, John, 1987, A Diet for a New America. Stillpoint Publishing; McDougall, John, 2000. The McDougall Program for Women; Plant, Jane and Tidey, Gill, 2003. Understanding, Preventing and Overcoming Osteoporosis. Virgin Books.
   27. IARC Cancer Epidemiology Database. GLOBOCAN 2000, Cancer incidence, mortality and prevalence worldwide. Ferlay, J., Bray, F., Piesci, P., and Parkin, D.M. (editors), www.dep.iarc.fr/globocan/ database.pdf
   28. Frassetto, L.A., Todd, K.M., Morris, R.C., Jr and Sebastian, A., 2000. Worldwide incidence of hip fracture in elderly women: relation to consumption of animal and vegetable food s. Journal of Gerontology: Medical Sciences, 55 A. 10, M585-M592.

   Дополнение к главе 4

   1. Jakes, Rupert W, Duffy, Stephen W, Ng, Fook-Cheong, Gao, Fei, Ng, Eng-Hen, Scow, Adeline, Lee, Hin-Peng and Yu, Mimi C., 2002. Mammographic Parenchymal Patterns and Self-re-ported Soy Intake in Singapore Chinese Women. Cancer Epidemiology Biomarkers & Prevention, 11, 608–613.
   2. Pringle, H., 1998. Neolithic agriculture: reading the signs of ancient animal domestication. Science. 282, 1448.
   3. Thomas M and others, 2007, Proc Nat Acad Sei.
   4. Latham, M.C., 1997. Human nutrition in the developing world, Rome, 1997. FAO Food and Nutrition Series № 29, Cornell University, Ithaca, NY.
   5. Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
   6. AbuGhazaleh, A.A. and others, 2004. CLA increases in milk when cows fed fish meal and extruded soybeans for an extended period of tim t. Journal of Dairy Science, 87 (6), 1758–1766.
   7. Petit, H.V., 2002. Digestion, milk production, milk composition, and blood composition of dairy cows fed whole flax seed. Journal of Dairy Science, 85 (6), 1482–1490.
   8. Wahle, K.W and others, 2004. CLAs: are they beneficial or detrimental to health? Progress in Lipid Research, 43 (6), 553–587.
   9. Willett, WC, and Stampfer, M.J., 2007. Rebuilding the food pyramid. Scientific American, Special edition on diet and health, February 2007, 12–21.
   10. The Royal Society, 2000. Endocrine-disrupting chemicals. Document 06/00. The Royal Society.
   11. Butler, J., 2006. White lies. Vegetarian and Vegan Foundation.
   12. Qin, L.Q. and others, 2004. Estrogen: one of the risk factors in milk for prostate cancer. Medical Hypotheses, 62 (1), 133–142.
   13. Hartman, S. and others, 1998. Natural occurrence of steroid hormones in food. Food Chemistry, 62, 7-20.
   14. Buder, J., 2006. White lies. Vegetarian and Vegan Foundation.
   15. Ganmaa, D. and Sato, A., 2005. Possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers. Medical Hypotheses, 65 (6), 1028–1037.
   16. DEFRA, 2005. Agriculture in the UK, 2004. Norwich, UK: HMSO.
   17. Campbell, T.C. and Junshi, C., 1994. Diet and chronic degen erative disease perspectives from China. Am J Clin Nutr, 59, Suppl., 11 535-11 615.
   18. Charatan, Fred, 2003. Book Review: Fat Land: How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.
   19. Charatan, Fred, 2003. Book Review: Fat Land: How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.
   20. Charatan, Fred, 2003. Book Review; Fat Land; How Americans Became the Fattest People in the World, by Greg Critser. BMJ, 326, 229.
   21. Grosvenor, C.E. and others, 1992. Hormones and growth factors in milk. Endocrine Reviews, 14 (6), 710–728.
   22. http://www.dhn.csiro.au/crctissue.html
   23. http://www.13.waisays.com/cancer2.htm
   24. le Huerou-Luron, I. and others, 1998. Source of dietary protein influences kinetics of plasma gut regulatory peptide concentration to feeding in preruminant calves. Comparative Biochemistry and Physiology: A – Molecular and Integrative Physiology, 119 (3), 817–824.
   25. Koldovski, O. and others, 1995. Milk-borne hormones: possible tools of communication between mother and suckling. Physiological Research, 1995, 44 (6), 349–351, Koldovsky, O. and others, 1994. Hormonally active peptides in human milk. Acta Paediatrica Suppl., 402, 89–93; Lehy,T. and others, 1990. Promoting effect of bombesin on the cell proliferation in the rat endocrine pancreas during the early post natal period. Regulatory Peptides, 27 (1), 87–96; Pollack, P.F., 1989. Effects of enterally– and parenterally-administrated bombesin on intestinal luminal tryptic activity and protein in the suckling rat. Ex-perienta, 45 (4), 385–388; Lazarus, L.H. and others, 1986. An immunoreactive peptide in milk contains bombesin-like bioactivity. Experienta, 42 (7), 822–823; Jahnke, G.D. and others, 1984. A bombesin immunoreactive peptide in milk. Proc Natl Acad Sei USA, 81 (2), 578–582.
   26. Berseth, C.I. and others, 1990. Postpartum changes in pattern of gastrointestinal regulatory peptides in human milk. Am J ClinNutr, 51 (6), 985–990.
   27. Burns, D.M. and others, 1999. Breast cancer cell-associated en-dopeptidase EC24.11 modulates proliferative response to bombesin, British Journal of Cancer, 79 (2), 214–220; Bold, R.J, and others, 1998. Bombesin stimulates in vitro growth of human breast cancer independent of estrogen receptor status. Anticancer Research, 18 (16A), 4051–4056; Miyazaki, M. and others, 1998. Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-11 and RC-3095. European Journal of Cancer, 34 (5), 710–717; Nelson, J, and others,
   1991. Bombesin stimulates proliferation of human breast cancer cells in culture. Br. J. Cancer, 63 (6), 933–936; Giacchetti, S. and others, 1990. Characterization, in some human breast can-
   cer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. Int J Cancer, 46 (2), 293–298; Weber, C.J. and others, 1989. Gastrin-releasing peptide, calcitonin gene-related peptide, and calcitonin-like immu-no-reactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines. Surgery, (6), 1134–1139 (disc. 1139–1140).
   28. Markwalder, R. and others, 1999. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Research, 59 (5), 1152–1159; Festuccia, C. and others, 1998. In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin. Int. J. Cancer, 75 (3); 418–431: Krongrad, A. and others, 1997. Endopeptidase 24.11 activity in the human prostate cancer cell lines LNCaP and PPC-1. Urological Research, 25 (2), 113–116; Jungwirth, A. and others, 1997. LHRH antagonist Cetrolix (SB-75) and bombesin-antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate, 32 (3), 164–172; Larran, J. and others, 1996. In vitro characterization of bombesin and calcitonin on the proliferation of PC3, DK145 and LNCaP cancer prostatic cell lines. International Journal of Developmental Biology, 1996 (Suppl. 1), 275S-276S; Aprickian, A.G. and others, 1996. Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostatic cancer cells. Journal of Molecular Endocrinology, 16 (3), 297–306; Bologna, M. and others, 1989. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer, 63 (9), 1714–1720; Wasilenko, WJ. and others, 1996. Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines. Int J Cancer, 68 (2), 259–264.
   29. Takeyama, M. and others, 1989. Enzyme immunoassae of gastrin-releasing, peptide (GRP)-like immunoreactivity in milk. Int J Pept Protein Res, 34 (1), 70–74.
   30. Ducroc, R. and others, 1995. Immunoreactive substance P and calcitonin-gene-related peptide (CGRP) in rat milk and in human milk and infant formula’s. Am J Clin Nutr, 62 (3), 554–558.
   31. Lembeck, F. and others, 1979. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Arch Pharmacol, 310 (2), 175–183.
   32. Khare, V K. and others, 1998. The neuropeptide/mast cell secretagogue substance F is expressed in cutaneous melano-cyticlesions. Journal of Cutaneous Pathology, 25 (1), 2-10.
   33. Ducroc, R. and others, 1995. Immunoreactive substance P and calcitonin-gene-related peptide (CGRP) in rat milk and in human milk and infant formula’s. Am J Clin Nutr, 62 (3), 554–558.
   34. Faulkner, A., 1998. Insulin-like growth factor 1 concentrations in milk and plasma after growth hormone treatment. Biochemical Society Transactions, 26 (4), 386; Silanikove, N. and others, 1998. Metabolic and productive response of dairy cows to increased ion supplementation at early lactation in warm weather. Journal of Dairy Research, 65 (4), 529–543; Ginjala, V. and others, 1998. Determination of transforming growth factor-beta 1 (TGF-beta 1) and insulin-like growth factor-1 (IGF-1) in bovine colostreum samples. Journal of Immunoassay, 19 (2–3), 195–207; Schober, D.A. and others, 1990. Perinatal expression of type 1 IGF receptors in porcine small intestine. Endocrinology, 126 (2), 1125–1132.
   35. Rao, R.K. and others, 1998. Luminal stability of insulin-like growth factor-1 and -2 in developing rat gastrointestinal tract. Journal of Pediatric Gastroenterology and Nutrition, 26 (2), 179–185.
   36. Parisot, J.P. and others, 1999. Altered expression of the insulinlike growth factor-1 receptor in a tamoxifen-resistant human breast cancer cell line. Br J Cancer, 79 (5–6), 693–700; Sciacca, L. and others, 1999. Insulin receptor activation by insulin-like growth factor-2 in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene, 18 (15), 2471–2479; Grothey, A. and others, 1999. The role of insuline-like growth factor and its receptor in cell growth transformation, apopto-sis, and chemoresistance In solid tumor s. Journal of Cancer Research and Clinical Oncology, 125 (3–4), 166–173; Perks, C. M. and others, 1999. Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor-1 (IGF-1) in human breast cancer cell lines. Br J Cancer, 79 (5–6), 701–706; de Cupis, A. and others, 1998. Responsiveness to hormone, growth factor and drug treatment of a human breast cancer cell line; comparison between early and late cultures. In Vitro Cellular and Developmental Biology – Animal, 34 (10), 836–843; Kobari, M. and others, 1998. The inhibitory effect of an epidermal growth factor receptor specific tyrokinase inhibitor on pancreatic cancer cell lines was more potent than inhibitory antibodies against the receptors for EGF and IGF-1. International Journal of Pancreatology, 24
   (2), 85–95; Gooch, J.L. and others, 1998. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res, 58 (18), 4199–4205; Choki, I. and others, 1998. Osteobiast-derived growth factors enhance adriamycin-cytos-tasis of MCF-7 human breast cancer cells. AnticancerRes, 18 (16A), 4213–4224; Jackson, J.G. and others, 1998, Insulin receptor substrate-1 is the predominant signalling molecule activated by insulin-like growth factor-1, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. Journal of Biological Chemistry, 273 (16), 9994-10 003; Westley,
   B.R. and others, 1998. Interactions between the oestrogen and IGF signalling pathways in the control of breast epithelial cell proliferation. Biochemical Society Symposium, 63, 35–44; Sur-macz, E. and others, 1995. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation. Clinical Cancer Research, 1 (11), 1429–1436.
Чтение онлайн



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 [70] 71 72 73 74 75 76 77

Навигация по сайту
Реклама


Читательские рекомендации

Информация